Cocrystal Pharma, Inc. (COCP): Total Assets
$9.71M
As of 2025-12-31
$4.65M
As of 2026-06-30
-38.0%
3-year compound annual growth
-29.1%
5-year compound annual growth
-26.9%
10-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $9.71M | -27.8% | 2026-03-31, Balance as of period end |
| 2024-12-31 | $13.46M | -57.0% | 2026-03-31, Balance as of period end |
| 2023-12-31 | $31.26M | -23.5% | 2025-03-31, Balance as of period end |
| 2022-12-31 | $40.84M | -48.6% | 2024-03-28, Balance as of period end |
| 2021-12-31 | $79.39M | +46.4% | 2023-03-29, Balance as of period end |
| 2020-12-31 | $54.24M | +90.1% | 2022-03-23, Balance as of period end |
| 2019-12-31 | $28.53M | -58.4% | 2021-03-17, Balance as of period end |
| 2018-12-31 | $68.56M | -43.5% | 2020-03-27, Balance as of period end |
| 2017-12-31 | $121.43M | -2.8% | 2019-04-01, Balance as of period end |
| 2016-12-31 | $124.88M | -44.3% | 2018-03-21, Balance as of period end |
| 2015-12-31 | $224.23M | -13.5% | 2017-03-31, Balance as of period end |
| 2014-12-31 | $259.28M | n/m | 2016-03-15, Balance as of period end |
| 2013-12-31 | $1.66M | -77.1% | 2015-03-31, Balance as of period end |
| 2012-12-31 | $7.24M | -4.1% | 2014-03-31, Balance as of period end |
| 2011-12-31 | $7.55M | +0.2% | 2013-04-01, Balance as of period end |
| 2010-12-31 | $7.53M | n/a | 2012-04-16, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Cocrystal Pharma, Inc. (COCP) | 2025-12-31 | $9.71M | -27.8% |
| MAIA Biotechnology, Inc. (MAIA) | 2025-12-31 | $9.70M | -4.4% |
| FibroBiologics, Inc. (FBLG) | 2025-12-31 | $9.62M | -41.5% |
| Can-Fite BioPharma Ltd. (CANF) | 2025-12-31 | $9.51M | +4.3% |
| Kala Bio, Inc. (KALA) | 2025-12-31 | $9.49M | -82.9% |
| Korsana Biosciences, Inc. (KRSA) | 2025-12-31 | $9.98M | +4.3% |
| Medicus Pharma Ltd. (MDCX) | 2025-12-31 | $10.06M | +78.2% |
| Oragenics Inc (OGEN) | 2025-12-31 | $10.07M | +583.7% |
| Indaptus Therapeutics, Inc. (INDP) | 2025-12-31 | $9.31M | +26.9% |
Compare COCP, MAIA, FBLG, CANF side by side · Screen every company in Pharmaceutical Preparations ↗